Improvement of sympathetic skin responses after enzyme replacement therapy in Fabry disease

被引：0
|
作者：
Jardim, LB
Becker, J
Neto, C
Nora, D
Matte, U
Pereira, F
Burin, M
Giugliani, R
Gomes, I
机构：
[1] Hosp Clin Porto Alegre, Neurol Serv, Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande Sul, Dept Internal Med, BR-90046900 Porto Alegre, RS, Brazil
[3] Univ Fed Rio Grande Sul, Dept Biochem, BR-90046900 Porto Alegre, RS, Brazil
[4] Hosp Clin Porto Alegre, Med Genet Serv, Porto Alegre, RS, Brazil
来源：
ACTA PAEDIATRICA | 2006年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：133 / 134
页数：2
相关论文
共 50 条
  • [41] Enzyme replacement therapy for Anderson-Fabry disease
    El Dib, Regina P.
    Pastores, Gregory M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (05):
  • [42] Fabry Disease Progression with and without Enzyme Replacement Therapy
    Nowak, Albina
    Koch, Gilbert
    van den Anker, Johannes
    Huynh-Do, Uyen
    Pfister, Marc
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S12 - S13
  • [43] Enzyme replacement therapy in Fabry disease: clinical implications
    Breunig, F
    Knoll, A
    Wanner, C
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2003, 12 (05): : 491 - 495
  • [44] Enzyme replacement therapy in patients with Fabry's disease
    Tsuboi, K.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2007, 35 (04) : 574 - 581
  • [45] Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease
    David F Moore
    Gheona Altarescu
    Peter Herscovitch
    Raphael Schiffmann
    BMC Neurology, 2
  • [46] Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease
    Moore, David F.
    Altarescu, Gheona
    Herscovitch, Peter
    Schiffmann, Raphael
    BMC NEUROLOGY, 2002, 2 (1)
  • [47] RENAL AND CARDIAC PATHOLOGY IN FABRY DISEASE AFTER 13 YEARS ON ENZYME REPLACEMENT THERAPY
    Talbot, A.
    Finlay, M.
    Nicholls, K.
    NEPHROLOGY, 2015, 20 : 31 - 31
  • [48] Cardiac function evaluation after 36 months of enzyme replacement therapy for Fabry disease
    Netto, C.
    Jardim, L.
    Cecchin, C.
    Burin, M.
    Brustolin, S.
    Rohde, L. E.
    Da Silva, L. Beck
    Giugliani, R.
    ACTA PAEDIATRICA, 2007, 96 : 104 - 105
  • [49] Ultrastructural Evidence of Glycosphingolipid Degradation After Enzyme Replacement Therapy in Patients With Fabry Disease
    Onoue, Kenji
    Takemura, Genzou
    Nakano, Tomoya
    Miyazaki, Nagisa
    Tsujimoto, Akiko
    Watanabe, Takatomo
    Okada, Hideshi
    Kanamori, Hiromitsu
    Sugiura, Junichi
    Kanaoka, Koshiro
    Ishihara, Satomi
    Horii, Manabu
    Akai, Yasuhiro
    Sakaguchi, Yasuhiro
    Saito, Yoshihiko
    CIRCULATION JOURNAL, 2019, 83 (10) : 2081 - +
  • [50] Evaluation of kidney function after 24 months of enzyme replacement therapy for Fabry disease
    Netto, C
    Cecchin, C
    Burin, M
    Matte, U
    Brustolin, S
    Barros, E
    Giugliani, R
    Jardim, L
    ACTA PAEDIATRICA, 2006, 95 : 135 - 135
12345